Next 10 |
home / stock / otsky / otsky news
2024-06-18 07:05:27 ET More on AstraZeneca AstraZeneca: The Price Upside Is Exhausted For Now (Rating Downgrade) AstraZeneca: Plotting A Bold Path To $80 Billion Revenues, I'm Pausing For Breath AstraZeneca: A Triple Shot Of Income, Growth, And Value AstraZen...
2024-05-22 12:29:46 ET More on Otsuka Historical earnings data for Otsuka Holdings Co., Ltd. Dividend scorecard for Otsuka Holdings Co., Ltd. Financial information for Otsuka Holdings Co., Ltd. Seeking Alpha’s Quant Rating on Otsuka Holdings Co., Ltd. ...
2024-05-17 10:53:56 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Otsuka Holdings (OTCMKTS: OTSKY ) just reported results for the first quarter of 2024. Otsuka Holdings reported earnings per share of 48 cents. The company reported re...
2024-04-30 09:30:31 ET More on Otsuka Holdings Co., Ltd. Seeking Alpha’s Quant Rating on Otsuka Holdings Co., Ltd. Historical earnings data for Otsuka Holdings Co., Ltd. Read the full article on Seeking Alpha For further details see: Otsuka Holding...
2024-04-24 09:30:00 ET Summary Artisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated clients globally. The portfolio solidly outperformed the MSCI AC World Index. Holdings in health ca...
2024-04-11 08:36:33 ET More on Alpine Immune Sciences Alpine Immune Sciences, Inc. (ALPN) Q4 2023 Earnings Call Transcript Alpine Immune Sciences: Track Record Undermines Case For Latest Lead Drug Vertex enters into agreement to acquire Alpine Immune Sciences ...
2024-01-25 15:30:27 ET Summary Vera Therapeutics, Inc. stock price soared over 35% today as it announced positive results from the open label extension of its Phase 2b ORIGIN clinical trial for atacicept in IgA nephropathy. The company's stock is up over 160% in the past year and ...
2024-01-21 13:30:00 ET Pharmaceutical companies would be wise to pay attention to developing new treatments for ADHD as there is a demand for improved drugs in the space. Currently, the medications of choice for the condition are stimulant drugs, such as Takeda's ( NYSE: TAK ) V...
2023-11-20 11:49:37 ET Summary Intra-Cellular Therapies, Inc. is a mid-cap biopharmaceutical company focused on developing treatments for neuropsychiatric and neurological disorders. The company's commercial asset, Caplyta, has achieved significant sales growth and is an exciting ...
2023-11-20 11:18:10 ET More on Medtronic Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings Medtronic Stock Is Simply Too Cheap To Ignore Medtronic Faces Potential Decline Despite Financial Strength Medtronic Q2 2024 Earnings Preview ...
News, Short Squeeze, Breakout and More Instantly...
Otsuka Holdings Co. Ltd. ADR Company Name:
OTSKY Stock Symbol:
OTCMKTS Market:
Ginkgo Bioworks (DNA) went public last September through an SPAC deal with Soaring Eagle Acquisition Corporation, a blank-check company led by former MGM CEO Harry Sloan. However, the stock has nosedived in price since its market debut. In addition, given an ongoing investigation into the com...
Biotech company Cassava Sciences (SAVA) is known for its Alzheimer’s drug, currently in phase three clinical trials. The stock has gained triple digits so far this year. However, with the SEC investigating claims that the company allegedly manipulated its prior clinical trial results, ...